Volterra Technologies’s Pfizer PFE Stock Holding History

Volterra Technologies’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-308,500	Closed	-$7.48M	–	513
2025 Q2	$7.48M	Buy	+308,500	New	+$7.19M	0.95%	18

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Volterra Technologies's PFE Position: Q2 2026 in Review

Volterra Technologies increased its Pfizer (PFE) stake by 154% in Q2 2026, buying an estimated $666K and bringing the position to 41,938 shares worth $1.01M. The position accounts for 0.15% of the portfolio, ranked #135.

Volterra Technologies first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Volterra Technologies held 41,938 shares of Pfizer worth $1.01M as of Q2 2026.
Volterra Technologies bought 25,451 Pfizer shares in Q2 2026, an estimated $666K.
Pfizer made up 0.15% of Volterra Technologies's portfolio in Q2 2026, its #135 holding.
Volterra Technologies first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Volterra Technologies's 13F filing for Q2 2026, filed 14 Aug 2026.